fda banned tirzepatide approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Eli Lilly's tirzepatide is off

Federal and state policymakers are exploring bipartisan reforms to regulate pharmacy benefit managers

Human data (from a meta-analysis of 894 participants) show fenugreek supplementation (0.5 g to 10 g daily over 4 weeks to 6 months) reduces fasting glucose, post-meal glucose, and HbA1c

Peptide and solution are to be combined by the end user to ensure product freshness

It is not a drug, food, or cosmetic and is not for human or animal consumption

It can reduce insulin resistance, improving glucose metabolism & overall diabetes management.

Many patients experience a weight loss plateau on Wegovy after initial success